One-day Seminar

“The role of high throughput epitope binning assays in guiding the discovery of therapeutic antibodies”

March 30th 2017, 9.30am – 4.00pm

Embassy Suites, 
250 Gateway Boulevard
South San Francisco, California, 94080


Epitope binning assays are routinely used in the discovery of therapeutic antibodies to sort candidates into families or “bins” based upon their specificity profiles. In this type of assay, antibodies are competed against one another in a pairwise and combinatorial fashion for binding to their specific antigen to generate a blocking fingerprint per antibody and those with similar fingerprints are clustered together in a “bin”.

At this conference we will demonstrate how throughput advances in label-free array-based surface plasmon resonance imaging are facilitating the analysis of large panels of antibodies by providing a deep insight into the epitope landscape of antibody campaigns, informing decision-making in the drug discovery process.


9.30 – 10.00
Arrival & coffee

10.00 – 10.30
Yasmina Abdiche, PhD, CSO, Wasatch Microfluidics

10.30 – 11.30
Bill Harriman, PhD, CSO and Co-Founder, Crystal Bioscience
“The use of epitope analysis to validate a novel in-vivo antibody discovery platform.”

11.30 – 12.30
Yik Andy Yeung, PhD, Associate Research Fellow, Oncology Research Unit, Pfizer-Rinat
“High-throughput epitope binning revealed unique modes of neutralization from human antibodies against a Staphylococcus aureus virulence factor.

12.30 – 1.30

1.30 – 2.30
Arvind Sivasubramanian, PhD, Senior Scientist, Adimab
“Broad epitope coverage of a human in-vitro antibody library, informed by epitope binning.”

2.30 – 3.30
Daniel Bedinger, PhD, West Coast Applications Scientist, Wasatch Microfluidics
“See your antibody diversity earlier with high throughput epitope binning data visualization and analysis software.”

3.30 – 4.00
Refreshments & Networking